TRIB Trinity Biotech: Company Value to Revenue Ratio

Official company branding of Trinity Biotech plc (TRIB)

Trinity Biotech plc (TRIB) is implementing energy-efficient equipment and recyclable packaging to reduce its environmental footprint. This chart's EV/Sales ratio visualizes the real value of the business without debt noise, where the 2897.73 mark serves as the current indicator. Risks are linked to debt load and pricing pressure from tenders, although stable European law and the humanitarian profile of the products minimize geopolitical threats.

TRIB Trinity Biotech Corp: Company Value to Revenue in the range 11/23/2025 - 11/19/2026

Financial and market metric breakdowns for Trinity Biotech (TRIB)

- market price and analyst price targets:
Fundamental company valuation:Trinity Biotech PLC - TRIB
Core merchandise of trinitybiotech.com

To objectively evaluate the issuer, it is essential for the manager to understand the ratio of market capitalization and net debt to annual turnover, which eliminates the impact of the financing structure on the business value. By analyzing the enterprise value-to-revenue multiple, the investor determines the premium paid for Trinity Biotech (TRIB) automated blood analysis systems, assessing the extent to which the market has priced in the efficiency of implementing digital optical readers.

Competitor analysis for Trinity Biotech plc

A (Agilent) - Company Value to Revenue Ratio|DGX (Quest Diagnostics) - Company Value to Revenue|Illumina Inc (ILMN) - EV/Sales Multiple|Company Value to Revenue EXAS|Revvity, Inc. (RVTY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple BIO|NNNN (Anbio Biotechnology) - Business Value to Revenue|EV/Sales Multiple SHC (Sotera Health)|Quidel Corporation (QDEL) - Enterprise Value-to-Revenue Multiple|OPK - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio CareDx Corp CDNA|Maravai LifeSciences (MRVI) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Sales Ratio Fulgent Genetics, Inc. FLGT|LAB (Standard BioTools Inc) - EV/Sales Multiple|Cytek Biosciences (CTKB) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple OSUR|Exagen - Company Value to Revenue Ratio|EV/Sales Multiple MDXH (MDxHealth, Inc.)|luciddx.com (LUCD) - Enterprise Value-to-Revenue Multiple|prenetics.com - EV/Sales Multiple|Insight Molecular Diagnostics, Inc. (IMDX) - Company Value to Revenue|PRPH (ProPhase) - Company Value to Revenue|Company Value to Revenue Ratio AIMD|Company Value to Revenue CODX|Enterprise Value-to-Revenue Multiple heartsciences.com HSCS|Enterprise Value-to-Revenue Ratio Biomerica Inc. (BMRA)|Total Company Value-to-Revenue Ratio Cardio Diagnostics Holdings|EV/Sales Multiple ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Enterprise Value-to-Revenue Multiple|bluejaydx.com - EV/Sales Multiple|Aspira Women's Health - Enterprise Value-to-Revenue Coefficient|AXDX (Accelerate Diagnostics) - Company Value to Revenue|Company Value to Revenue CENTOGENE, N.V.|Enterprise Value-to-Revenue Ratio enzo.com|EV/Sales Multiple Fresh2 Group Limited|EV/Sales Multiple GENE|23andMe Holding Co. - Company Value to Revenue Ratio|Psychemedics Inc - Company Value to Revenue